AKT 1/2 Inhibitor BAY1125976

An orally bioavailable inhibitor of the serine/threonine protein kinase AKT (protein kinase B) isoforms 1 and 2 (AKT1/2) with potential antineoplastic activity. AKT1/2 inhibitor BAY1125976 selectively binds to and inhibits the phosphorylation and activity of AKT1/2 in a non-ATP competitive manner, which may result in the inhibition of the phosphatidylinositol 3 (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling pathway. This may lead to both the reduction of cell proliferation and the induction of cell apoptosis in AKT-overexpressing tumor cells. The AKT signaling pathway is often deregulated in cancer and is associated with tumor cell proliferation, survival and migration. (NCI Thesaurus)

YOU MAY ALSO LIKE

Akt

A group of enzymes involved in several processes related to cell growth and survival. Akt enzymes help to transfer signals inside…

Akrotiri

A British Overseas Territory comprising a peninsula on the southern coast of Cyprus.

AKR7A2 wt Allele

Human AKR7A2 wild-type allele is located within 1p35.1-p36.23 and is approximately 8 kb in length. This allele, which encodes aflatoxin B1 aldehyde…

AKR7A2 Gene

This gene is involved in the detoxification of xenobiotics.

AKR1C2 wt Allele

Human AKR1C2 wild-type allele is located within 10p15-p14 and is approximately 30 kb in length. This allele, which encodes aldo-keto reductase family…

AKR1C2 Gene

This gene plays a role in the metabolism of steroid hormones.